David L. Marchetti

405 total citations
12 papers, 293 citations indexed

About

David L. Marchetti is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, David L. Marchetti has authored 12 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 4 papers in Surgery. Recurrent topics in David L. Marchetti's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Uterine Myomas and Treatments (3 papers). David L. Marchetti is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Uterine Myomas and Treatments (3 papers). David L. Marchetti collaborates with scholars based in United States. David L. Marchetti's co-authors include M. Steven Piver, Shashikant Lele, Deborah L. Driscoll, Shashikant B. Lele, Myroslaw M. Hreshchyshyn, Lawrence J. Emrich, Leslie E. Blumenson, Kunle Odunsi, Trudy R. Baker and Roger L. Priore and has published in prestigious journals such as Cancer, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

David L. Marchetti

12 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Marchetti United States 12 171 138 75 68 54 12 293
J.T. Chambers United States 10 221 1.3× 205 1.5× 49 0.7× 60 0.9× 38 0.7× 23 358
G. Rangoni Italy 10 143 0.8× 88 0.6× 111 1.5× 69 1.0× 68 1.3× 26 362
L Savino Italy 11 213 1.2× 248 1.8× 82 1.1× 54 0.8× 36 0.7× 19 378
Peter R. Dottino United States 10 151 0.9× 108 0.8× 66 0.9× 114 1.7× 36 0.7× 30 282
DiSaia Pj United States 11 142 0.8× 143 1.0× 66 0.9× 73 1.1× 123 2.3× 21 348
Masashi Nishiya Japan 9 203 1.2× 225 1.6× 54 0.7× 78 1.1× 40 0.7× 18 388
Andrew Evans United Kingdom 7 178 1.0× 78 0.6× 34 0.5× 64 0.9× 39 0.7× 8 295
Allan J. Jacobs United States 9 180 1.1× 139 1.0× 59 0.8× 100 1.5× 31 0.6× 19 321
Elisabet Björkholm Sweden 9 263 1.5× 108 0.8× 74 1.0× 79 1.2× 40 0.7× 10 387
Madeline Mason United States 3 205 1.2× 143 1.0× 30 0.4× 105 1.5× 32 0.6× 8 287

Countries citing papers authored by David L. Marchetti

Since Specialization
Citations

This map shows the geographic impact of David L. Marchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Marchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Marchetti more than expected).

Fields of papers citing papers by David L. Marchetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Marchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Marchetti. The network helps show where David L. Marchetti may publish in the future.

Co-authorship network of co-authors of David L. Marchetti

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Marchetti. A scholar is included among the top collaborators of David L. Marchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Marchetti. David L. Marchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Villella, Jeannine, François R. Herrmann, Shashikant Lele, et al.. (2007). Clinical and Pathological Predictive Factors in Women with Adult-type Granulosa Cell Tumor of the Ovary. International Journal of Gynecological Pathology. 26(2). 154–159. 21 indexed citations
2.
Olawaiye, Alexander, Debra Walsh, John Yeh, et al.. (2004). Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers. Gynecologic Oncology. 94(3). 796–802. 11 indexed citations
3.
Pejović, Tanja, Daniela P. Ladner, Marilyn Intengan, et al.. (2004). Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. European Journal of Cancer. 40(16). 2519–2524. 19 indexed citations
4.
Villella, Jeannine, David L. Marchetti, Kunle Odunsi, et al.. (2004). Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma. Gynecologic Oncology. 95(3). 539–545. 17 indexed citations
5.
Eltabbakh, Gamal H., M.Steven Piver, Ronald E. Hempling, et al.. (1998). Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer. Gynecologic Oncology. 70(3). 392–397. 32 indexed citations
6.
Marchetti, David L., et al.. (1993). Treatment of Advanced Ovarian Carcinoma in the Elderly. Gynecologic Oncology. 49(1). 86–91. 33 indexed citations
7.
Marchetti, David L., et al.. (1991). Ovarian endodermal sinus tumor associated with pregnancy: Review of the literature. Gynecologic Oncology. 41(2). 156–160. 25 indexed citations
8.
Marchetti, David L., et al.. (1990). Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes. Gynecologic Oncology. 37(1). 51–54. 15 indexed citations
9.
Piver, M. Steven, John H. Malfetano, Trudy R. Baker, Shashikant B. Lele, & David L. Marchetti. (1989). Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary report. Gynecologic Oncology. 35(1). 69–72. 18 indexed citations
10.
Piver, M. Steven, Shashikant Lele, David L. Marchetti, & Lawrence J. Emrich. (1988). Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. Journal of Surgical Oncology. 38(4). 233–239. 38 indexed citations
11.
Piver, M. Steven, et al.. (1988). Radical Hysterectomy and Pelvic Lymphadenectomy Versus Radiation Therapy for Small (≤3 cm) Stage IB Cervical Carcinoma. American Journal of Clinical Oncology. 11(1). 21–24. 35 indexed citations
12.
Piver, M. Steven, David L. Marchetti, K. L. Parthasarathy, Suraj P. Bakshi, & Peter Reese. (1985). Doxorubicin hydrochloride (adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography. Cancer. 56(1). 76–80. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026